WO1998013087A2 - Needleless injector accessory - Google Patents
Needleless injector accessory Download PDFInfo
- Publication number
- WO1998013087A2 WO1998013087A2 PCT/GB1997/002626 GB9702626W WO9813087A2 WO 1998013087 A2 WO1998013087 A2 WO 1998013087A2 GB 9702626 W GB9702626 W GB 9702626W WO 9813087 A2 WO9813087 A2 WO 9813087A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- injection
- location
- skin
- injector
- member according
- Prior art date
Links
- 238000002347 injection Methods 0.000 claims abstract description 37
- 239000007924 injection Substances 0.000 claims abstract description 37
- 239000000463 material Substances 0.000 claims abstract description 12
- 239000000853 adhesive Substances 0.000 claims description 12
- 230000001070 adhesive effect Effects 0.000 claims description 12
- 239000010410 layer Substances 0.000 claims description 5
- 230000000844 anti-bacterial effect Effects 0.000 claims description 3
- 230000002924 anti-infective effect Effects 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 2
- 239000011241 protective layer Substances 0.000 claims 3
- 230000000694 effects Effects 0.000 claims 2
- 230000001419 dependent effect Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 5
- 230000002745 absorbent Effects 0.000 description 4
- 239000002250 absorbent Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 3
- 230000002458 infectious effect Effects 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 239000012790 adhesive layer Substances 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 239000003566 sealing material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00051—Accessories for dressings
- A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive plasters or dressings
- A61F13/0203—Adhesive plasters or dressings having a fluid handling member
- A61F13/0206—Adhesive plasters or dressings having a fluid handling member the fluid handling member being absorbent fibrous layer, e.g. woven or nonwoven absorbent pad, island dressings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive plasters or dressings
- A61F13/0203—Adhesive plasters or dressings having a fluid handling member
- A61F13/0226—Adhesive plasters or dressings having a fluid handling member characterised by the support layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/30—Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules
Definitions
- This invention relates to an accessory for use in the needleless injection of a stream of injectate through the skin of a subject.
- Needleless injectors are used as an alternative to needle-type hypodermic syringes for delivering liquid drugs and medicaments directly through the patient's skin and into the tissues without using a hollow needle.
- Such injectors consist of a piston pump driven by a spring or pressurised gas, which ejects the liquid drug or medicament through a small discharge orifice at a sufficient rate and pressure to pierce the skin and enter the tissues through the hole thus formed.
- Such injectors have been known for over fifty years, and, until recently, multi- dose injectors were a common device for vaccinating large numbers of people economically.
- multi-dose injectors could pick up infectious body fluid from one patient and transfer it to the next. This occurred as the result of the nozzle and its surrounding structure touching the skin: either infectious fluid already on the skin or a slight reflux of infectious blood through the injection hole in the skin would be sufficient to contaminate the nozzle. Consequently, multi-dose injectors are now hardly used except in veterinary applications.
- injectors have the lowest cost per dose of any parenteral delivery system, and there have been attempts recently to provide injectors which have the drug delivered from a disposable capsule attached manually to the injector.
- injectors which have the drug delivered from a disposable capsule attached manually to the injector.
- such methods can be inconvenient, and they certainly add to the cost.
- a member for use in needleless injection of a stream of injectate through the skin of a subject said member being suitable for placing in contact with the skin during injection and being piercable by the stream of injectate when delivered thereto at pressure such that after passage through the member it is at a pressure suitable for passage through the skin.
- the member is preferably in the form of a self adhesive patch formed of a thin plastics material. Needleless injectors may be designed to have ample power to pierce such a patch without detriment to the injection efficiency.
- the patch material is substantially self-sealing immediately after the injection, i.e. the hole produced in the patch by the injection has a tendency to close up and prevent reflux of injectate and/or blood.
- the patch material may be coated or impregnated with a disinfectant, anti-bacterial material, or other an ti- infection material.
- the advantage of the injection patch is that each patient's skin is covered before contact with the injector nozzle, and there is thus no contamination of the nozzle.
- the patch material closes the wound to prevent oozing of the fluid.
- the patch may include an absorbent layer, or the patch material itself may be absorbent, so as to further reduce the chance of contaminating the injector nozzle.
- the patch is left in place for a short time until the injectate has dispersed somewhat within the tissues. This has the added advantage that scratching of the infection site is prevented whilst the patch is in place. This is similar to the recommended practice of holding a sterile swab in place after any type of injection.
- the patches may be applied by the patients or by an assistant, or automatically by a device attached to the injector. If the patches are applied some minutes prior to the injection, the outer surface is preferably protected from contamination by a tamper-evident film, which is removed immediately before the injection.
- the patches may be releasably pre-assembled onto a carrier strip, and protected by a further strip or individual cover, the whole being sterilised.
- An alternative to using individual patches is to use a continuous strip of material which may be automatically indexed past the nozzle to protect it for each injection. This, however, does not have the advantage of continuing the protection of the injection site for a short time after the injection.
- Figure 1 is a perspective view showing a member in the form of a patch
- Figure 2 is a diagrammatic representation of a continuous strip of patches
- Figure 3 is a perspective view of a needleless injector fitted with a cartridge for feeding patches automatically;
- Figure 4 is a cross-section through the cartridge of Figure 3, and showing also part of the needleless injector of Figure 3 prior to firing;
- Figure 5 is a view corresponding to Figure 4 but showing the injector as it is fired.
- patch 1 comprises a flexible, skin-protecting film
- the film 2 preferably formed of a suitable plastics material such as polyethylene or a self- sealing material sold under the Trade Mark PARAFILM.
- the film 2 has a surface
- the surface of the skin-contacting film 2 which is on the other side of the film to the surface 3 is coated with a layer of adhesive 5, which in turn may be protected by a removable release film 6.
- the adhesive 5 is selected to be suitable to be adhered to the patient's skin. Often there is a small reverse flow of medicament after an injection, and to allow for this the skin-contacting film 2 may be absorbent and antibacterial (or anti-infection in some other way), or may have a layer of material thereon which is absorbent and anti-infection.
- the colour of the protective film 4 is different to that of the skin- contacting film 2, or it is visually distinguishable in some other way, for example by giving it a pattern, e.g. of stripes, to enable immediate recognition that the film has been removed and the sterile surface is exposed.
- the patch is used by removing the release film and sticking the patch to the patient's injection site. Immediately before the injection is given, the protective film
- the injector nozzle is pressed against the skin-contacting film 3 and the injectate is fired through that film and through the adhesive layer 5.
- the film 3 and the adhesive layer 5 are integrated with one another to a sufficient extent to ensure that there is no possibility of small pieces of film 3 or adhesive 5 being torn away and injected into the patient.
- Figure 3 shows a multi dose injector 7 with a cartridge 8 removably attached to the injection end thereof, so as to enable a plurality of injections to be given successively, each through a respective patch applied automatically to the skin of the patient.
- the injector 7 has an injection nozzle 7a (see Figures 4 and 5).
- the cartridge 8 is shown in more detail in Figure 4.
- the cartridge 8 comprises a housing 9 within which a carrier strip 10 having a plurality of patches 1 thereon is wound up on a reel 11.
- the cartridge 8 has a yoke 12 by means of which it is removably attached to the front end of the injector 7.
- the barrel 13 of the injector is fixedly mounted in a passageway 14 formed in the yoke 12.
- a compression spring 15 surrounds the barrel 13 and bears against the yoke 12 at one end and, at the other end, against an abutment 16 fixedly mounted with the casing 9.
- the yoke 12 is free to slide within a collar 17 which forms an extension from the main body of the casing 9.
- the carrier strip 10, with the patches 1 carried thereon, is wound on a spool 11.
- the free end of the strip is threaded over support rollers 18 which are positioned either side of an opening 19 in the front of the casing.
- the strip passes over a drive wheel 20 and through a nip formed between the drive wheel 20 and a pinch roller 21.
- the latter keeps the strip in fric onal contact with the surface of the drive wheel, so that when the drive wheel rotates in the direction of the arrow R, by the means described below, the carrier strip is pulled from the spool.
- the strip exits the cartridge through an opening 22.
- the drive wheel 15 has a toothed wheel 23 mounted coaxially thereon for rotation therewith.
- a pawl 24 is urged into engagement with the toothed wheel 23 by a compression spring 25, and a rack 26, pivotally mounted on the yoke 12, is also urged into contact with the toothed wheel 23, this time by means of a tension spring 27 acting between the rack and the yoke.
- the front of the cartridge 8 is placed on the patient's skin 28, with the opening 19 opposite the intended injection site.
- the injector 7 is pushed towards the patient's skin 28 in the direction of the arrow F, which causes the yoke 12 to move in the same direction, from the position shown in Figure 4 to that shown in Figure 5.
- the nozzle 7a of the injector 7 presses against the patch located opposite the opening 19, which is thereby pressed onto'the skin 28, and the injector is operated at this point and the injectate is fired through the patch and into the patient's tissues.
- the pawl 24 prevents movement of the drive wheel 20. It is greatly preferred that the injector should operate automatically on reaching the optimum skin contact force, and an injector which operates in this manner is described in PCT published application WO 93/03779, to which attention is directed for further details.
- the patch becomes detached from the carrier strip 10 as a result of the above- described operation, and remains adhered to the patient's skin after removal of the injector nozzle 7a, thus providing short-term protection for the wound, and containing any reflux of injectate.
- spring 15 returns the cartridge 8 to the position shown in Figure 4, and the rack 26 indexes the drive wheel 20 in the direction of arrow R to move the next patch into position for application.
- FIG 2 is a diagram showing the structure of an embodiment of carrier strip 10, with patches 1 , for use in the device described above.
- the carrier strip comprises a film 30, with a release film 31 on one face thereof, to prevent the patch adhesive 5 (see below) from sticking to the film 30 when the strip is rolled up, and adhesive 32 on the opposite face.
- the patches are secured to the strip by means of the adhesive 32.
- Each patch 1 comprises a skin-contacting film 2 and adhesive 5, as in the case of the patches shown in Figure 1 , and on the face adjacent the carrier strip 10 each patch has a release film 33 to enable it to detach itself readily from the carrier strip after injection.
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU43914/97A AU4391497A (en) | 1996-09-27 | 1997-09-26 | Needleless injector accessory |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9620184.3 | 1996-09-27 | ||
GBGB9620184.3A GB9620184D0 (en) | 1996-09-27 | 1996-09-27 | Needleless injector accessory |
GB9620270.0 | 1996-09-30 | ||
GBGB9620270.0A GB9620270D0 (en) | 1996-09-30 | 1996-09-30 | Needleless injector accessory |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1998013087A2 true WO1998013087A2 (en) | 1998-04-02 |
WO1998013087A3 WO1998013087A3 (en) | 1998-05-07 |
Family
ID=26310117
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1997/002626 WO1998013087A2 (en) | 1996-09-27 | 1997-09-26 | Needleless injector accessory |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU4391497A (en) |
WO (1) | WO1998013087A2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001026717A1 (en) * | 1999-10-11 | 2001-04-19 | Needleless Ventures, Inc. | Universal anti-infectious protector for needleless injectors |
WO2003028797A1 (en) * | 2001-09-28 | 2003-04-10 | Hewlett-Packard Company | Cutaneous administration system |
WO2007071485A1 (en) * | 2005-12-20 | 2007-06-28 | Novo Nordisk A/S | Skin retention device for a medical jet injection unit |
JP2009525094A (en) * | 2006-01-31 | 2009-07-09 | ノボ・ノルデイスク・エー/エス | Pre-filled medical jet injection device seal |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993003779A1 (en) | 1991-08-23 | 1993-03-04 | Weston Medical Limited | Needleless injector |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2764934A (en) * | 1952-06-21 | 1956-10-02 | Kaplan Irving | Combined printing device and tape applicator |
US3745083A (en) * | 1971-02-04 | 1973-07-10 | Kelly T | Apparatus for visually marking an article with characters over an opaque background covering |
FR2625438A1 (en) * | 1988-01-05 | 1989-07-07 | Cediat Mediffusion | Kit assembly intended for carrying out medicinal injections or (and) biological and/or pathological sampling |
DE3838061A1 (en) * | 1988-11-10 | 1990-05-23 | Holzer Walter | STERILE SELF-ADHESIVE FILM FOR MEDICAL PREPARATION |
DE69424698T2 (en) * | 1993-03-01 | 2001-02-22 | Johnson & Johnson Consumer | Process for the production of an adhesive bandage |
AU7009994A (en) * | 1993-08-11 | 1995-02-28 | Michael John Smith | Improvements in and relating to dressings |
-
1997
- 1997-09-26 WO PCT/GB1997/002626 patent/WO1998013087A2/en active Application Filing
- 1997-09-26 AU AU43914/97A patent/AU4391497A/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993003779A1 (en) | 1991-08-23 | 1993-03-04 | Weston Medical Limited | Needleless injector |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001026717A1 (en) * | 1999-10-11 | 2001-04-19 | Needleless Ventures, Inc. | Universal anti-infectious protector for needleless injectors |
WO2003028797A1 (en) * | 2001-09-28 | 2003-04-10 | Hewlett-Packard Company | Cutaneous administration system |
US6723077B2 (en) | 2001-09-28 | 2004-04-20 | Hewlett-Packard Development Company, L.P. | Cutaneous administration system |
US7544190B2 (en) | 2001-09-28 | 2009-06-09 | Hewlett-Packard Development Company, L.P. | Cutaneous administration system |
WO2007071485A1 (en) * | 2005-12-20 | 2007-06-28 | Novo Nordisk A/S | Skin retention device for a medical jet injection unit |
JP2009519798A (en) * | 2005-12-20 | 2009-05-21 | ノボ・ノルデイスク・エー/エス | Skin holding device for medical jet injection unit |
US8652095B2 (en) | 2005-12-20 | 2014-02-18 | Novo Nordisk A/S | Skin retention device for a medical jet injection kit |
JP2009525094A (en) * | 2006-01-31 | 2009-07-09 | ノボ・ノルデイスク・エー/エス | Pre-filled medical jet injection device seal |
US8920365B2 (en) | 2006-01-31 | 2014-12-30 | Novo Nordisk A/S | Seal for a prefilled medical jet injection device |
Also Published As
Publication number | Publication date |
---|---|
AU4391497A (en) | 1998-04-17 |
WO1998013087A3 (en) | 1998-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8162892B2 (en) | Injector device for placing a subcutaneous infusion set | |
US4685902A (en) | Disposable reservoir cassette | |
EP1673133B1 (en) | Fluid medication delivery device | |
US20030229308A1 (en) | Injector adapter and combination thereof | |
US20100076400A1 (en) | Method and device for painless injection of medication | |
US20060287631A1 (en) | Universal protector cap with auto-disable features for needle-free injectors | |
US20100036325A1 (en) | Medical Needle Safety Device | |
US11738148B2 (en) | Low profile intuitive pharmaceutical injection device | |
US20220211940A1 (en) | Drug Delivery Device with Needle Hub | |
WO1998013087A2 (en) | Needleless injector accessory | |
US9022987B2 (en) | Delivery system for injection through zone of body | |
US20050059933A1 (en) | Safety intravenous (IV) catheter assembly | |
US8465463B2 (en) | Medicament dispensing devices and methods | |
US20210236724A1 (en) | Infusion set for an infusion device | |
EP0197179B1 (en) | Disposable reservoir cassette | |
EP0197180A1 (en) | Reusable injection catheter | |
EP1441789B1 (en) | Universal protector cap with auto-disable features for needle-free injectors | |
NZ211821A (en) | Disposable reservoir cassette for a liquid medication delivery system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: JP Ref document number: 1998515409 Format of ref document f/p: F |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |